Spruce Biosciences Funding: $88M Raised, Series B (2020)
Spruce Biosciences is based in South San Francisco. It has raised $88M in total funding. Latest round: Series B.
Spruce Biosciences funding overview
Spruce Biosciences is based in South San Francisco. Spruce Biosciences has raised $88M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2020. The round record for Spruce Biosciences runs through 2020; nothing later has been disclosed. Investors on record include Omega Funds, Abingworth Bioventures, Novo Holdings, RiverVest Venture Partners, HealthCap, Rock Springs Capital and 3 others. 9 distinct backers are named across the disclosed rounds.
Spruce Biosciences at a glance
Total raised
$88M
Latest round
Series B
Latest round date
January 2020
Headquarters
South San Francisco
Notable investors
Omega Funds, Abingworth Bioventures, Novo Holdings, RiverVest Venture Partners, HealthCap, Rock Springs Capital, Aisling Capital, Surveyor Capital
Frequently asked about Spruce Biosciences funding
How much has Spruce Biosciences raised?
Spruce Biosciences has raised $88M in total disclosed funding across the rounds on record.
Who has invested in Spruce Biosciences?
Omega Funds, Abingworth Bioventures, Novo Holdings, RiverVest Venture Partners, HealthCap, Rock Springs Capital are named among the investors backing Spruce Biosciences.
What was the latest Spruce Biosciences funding round?
The most recent disclosed round is a Series B, announced in January 2020.
Where is Spruce Biosciences based?
Spruce Biosciences is based in South San Francisco.
When did Spruce Biosciences last raise?
The last disclosed Spruce Biosciences round closed in January 2020 at Series B.
Totals shown for Spruce Biosciences aggregate every disclosed round on file. To see how that compares, browse the companies in South San Francisco and the investors behind them below.
